Fortress Biotech, Inc.·4

Jul 21, 4:13 PM ET

Klein Dov 4

4 · Fortress Biotech, Inc. · Filed Jul 21, 2017

Insider Transaction Report

Form 4
Period: 2017-07-14
Klein Dov
Director
Transactions
  • Disposition to Issuer

    Common Stock, par value $0.001

    2017-07-1413,333201,668 total
  • Award

    Deferred Restricted Stock Units

    2017-07-14+13,33353,332 total
    Exercise: $0.00Common Stock (13,333 underlying)
Holdings
  • Common Stock, par value $0.001

    (indirect: By Spouse)
    1,800
Footnotes (2)
  • [F1]The Reporting Person was granted 50,000 shares of restricted common stock of the Issuer in July 2015 for his service on the Issuer's Board of Directors. The shares vest one-third annually beginning on July 15, 2016. The Reporting Person deferred the receipt of 80% of the vested shares on July 14, 2017 and instead received 13,333 shares of deferred restricted stock units pursuant to the Issuer's Deferred Compensation Plan for Directors (the "Plan"). As a result, the Reporting Person is reporting the disposition of 13,333 shares of Issuer common stock in exchange for an equal number of deferred restricted stock units.
  • [F2]Each deferred restricted stock unit will be settled in one share of the Issuer's common stock at the time and in the manner set forth in the Plan.

Documents

1 file
  • 4
    doc4_4850.xmlPrimary

    PRIMARY DOCUMENT